# HYDROGENATED CASTOR OIL

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid8027666
Categories: beauty, cleaning, industrial, pharma
Functions: Anti-adhesive/cohesive, Emulsifier, Fragrance, Humectant, Lubricating agent, Plasticizer, Processing aids not otherwise specified, Softener and conditioner, Surfactant (surface active agent), Thickening agent, Viscosity modifier, Wetting agent (non-aqueous)
Identifier: DTXSID8027666

> HYDROGENATED CASTOR OIL is used as anti-adhesive/cohesive / emulsifier. EPA CPDat observed this chemical in 1858 composition records across product categories including Vehicle, Home maintenance, Electronics/small appliances. Assessed from 17 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 1858 composition records across product categories including Vehicle, Home maintenance, Electronics/small appliances.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 1858 composition records across product categories including Vehicle, Home maintenance, Electronics/small appliances. EPA CPDat classifies this chemical for functional uses including Emulsifier, Viscosity modifier, Surfactant (surface active agent).
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 405 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Potency: 3.1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 410.82 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 232 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 1337 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 393 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 17 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 17 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 1.6 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 2 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: LIQUID; Potency: 0.24 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION; Maximum daily exposure: 286 mg
- US: marketed drug occurrence — FDA NDC lists this ingredient in 3 active drug products and 4 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as structurallydiverse.

_Assessed by Greenveil._